Advertisement

Incidence of metabolic syndrome in rural pre-menopausal women and associated risk factors

  • Dimple JamkhandiEmail author
  • Anu Mary Oommen
  • Kuryan George
  • Jasmin Prasad
Original Article
  • 3 Downloads

Abstract

The prevalence of metabolic syndrome (MetS) is increasing in the Asia Pacific region, as well as globally. This study was aimed at determining the incidence of MetS and associated risk factors among pre-menopausal women in rural Vellore, Tamil Nadu, South India. A community-based non-concurrent cohort design was used to study the incidence and risk factors associated with MetS in women from a rural block in Vellore district. Pre-menopausal women aged 38–45 years free of MetS in 2011–2012 were followed up 5 years later, for MetS. Body mass index (BMI), waist circumference, blood pressure, fasting glucose, and lipids were measured in addition to diet and physical activity. Cumulative incidence was calculated, and adjusted odds ratios (OR) obtained using logistic regression to measure association with risk factors. The cumulative 5-year incidence of metabolic syndrome among women aged 38–45 years was 32.5% (95% confidence interval (CI), 25.9–39. 1%). Women engaged in moderate physical activity alone were more likely to have MetS than those with vigorous activity (adjusted odds ratio (OR), 2.68; 95% confidence interval, 1.08–6.69). Those with BMI ≥ 23 kg/m2 were more likely to have MetS compared to those with a lower BMI (adjusted OR, 10.38; 95% CI, 3.50–30.80). Around one-third of pre-menopausal women aged 38–45 years developed metabolic syndrome within 5 years, in rural Vellore, South India. This high incidence emphasizes the need for raising awareness about risk factors for metabolic syndrome and encouraging lifestyle changes that may eventually help in reducing overall cardiovascular risk.

Keywords

Metabolic syndrome Incidence Pre-menopausal women 

Notes

Funding

This work received financial support from the Fluid Research Grant, Christian Medical College Vellore (IRB Min No 10249).

Compliance with ethical standards

Conflict of interest

The authors declare that there was no conflict of interests.

Ethical approval

The study was approved by the Institutional Review Board of the institution. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    World Health Organization. WHO | Global status report on noncommunicable diseases 2014 [Internet]. WHO. 2014 [cited 2018 Aug 24]. Available from: http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed 17 April 2018.
  2. 2.
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med J Br Diabet Assoc. 1998;15(7):539–53.CrossRefGoogle Scholar
  3. 3.
    Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ Can Med Assoc J J Assoc Medicale Can. 2007;176(6):S1–44.CrossRefGoogle Scholar
  4. 4.
    Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women’s Health Across the Nation. Arch Intern Med. 2008;168(14):1568–75.CrossRefGoogle Scholar
  5. 5.
    Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010;50(3):99–105.CrossRefGoogle Scholar
  6. 6.
    Tong J, Boyko EJ, Utzschneider KM, McNeely MJ, Hayashi T, Carr DB, et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia. 2007;50(6):1156–60.CrossRefGoogle Scholar
  7. 7.
    Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60(1):10–8.CrossRefGoogle Scholar
  8. 8.
    Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Metabolic syndrome in South Asians. Indian J Endocrinol Metab. 2012;16(1):44–55.CrossRefGoogle Scholar
  9. 9.
    Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497–514. CrossRefGoogle Scholar
  10. 10.
    Prabhakaran D, Chaturvedi V, Shah P, Manhapra A, Jeemon P, Shah B, et al. Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization. Chronic Illn. 2007;3(1):8–19.CrossRefGoogle Scholar
  11. 11.
    Chow CK, Naidu S, Raju K, Raju R, Joshi R, Sullivan D, et al. Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis. 2008;196(2):943–52.CrossRefGoogle Scholar
  12. 12.
    Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34.CrossRefGoogle Scholar
  13. 13.
    Oommen AM, Abraham VJ, George K, Jose VJ. Prevalence of risk factors for non-communicable diseases in rural & urban Tamil Nadu. Indian J Med Res. 2016;144(3):460–71.CrossRefGoogle Scholar
  14. 14.
    GBD. Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl. 2016. 2015;388(10053):1659–724.Google Scholar
  15. 15.
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefGoogle Scholar
  16. 16.
    IPAQ Research Committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ) – short and long forms , 2005. 2005.Google Scholar
  17. 17.
    Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRefGoogle Scholar
  18. 18.
    Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016;106(1):74–8.CrossRefGoogle Scholar
  19. 19.
    World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Health Communications Australia; 2000 [cited 2018 Apr 17]. Available from: http://iris.wpro.who.int/handle/10665.1/5379. Accessed 17 April 2018.
  20. 20.
    Singh T, Sharma S, Nagesh S. Socio-economic status scales updated for 2017. Int J Res Med Sci. 2017;5(7):3264.CrossRefGoogle Scholar
  21. 21.
    National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143–421.CrossRefGoogle Scholar
  22. 22.
    Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One. 2013;8(9):e76304.CrossRefGoogle Scholar
  23. 23.
    Khanam MA, Qiu C, Lindeboom W, Streatfield PK, Kabir ZN, Wahlin Å. The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One. 2011;6(6):e20259.CrossRefGoogle Scholar
  24. 24.
    Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58(8):1102–8.CrossRefGoogle Scholar
  25. 25.
    Selvaraj I, Gopalakrishnan S, Logaraj M. Prevalence of metabolic syndrome among rural women in a primary health centre area in Tamil Nadu. Indian J Public Health. 2012;56(4):314–7.CrossRefGoogle Scholar
  26. 26.
    Vaidya R, Pandey S, Srinivas M, Agashe S, Joshi J, Galvankar P, et al. Menopause and metabolic syndrome: a study of 498 urban women from western India. J -Life Health. 2010;1(2):63–9.CrossRefGoogle Scholar
  27. 27.
    Sharma S, Aggarwal N, Joshi B, Suri V, Badada S. Prevalence of metabolic syndrome in pre- and post-menopausal women: a prospective study from apex institute of North India. J -Life Health. 2016;7(4):169.CrossRefGoogle Scholar
  28. 28.
    Lee PH, Macfarlane DJ, Lam T, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8(1):115.CrossRefGoogle Scholar
  29. 29.
    Fogelholm M, Kukkonen-Harjula K. Does physical activity prevent weight gain--a systematic review. Obes Rev Off J Int Assoc Study Obes. 2000;1(2):95–111.CrossRefGoogle Scholar
  30. 30.
    Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol Bethesda Md 1985. 2005;99(1):338–43.Google Scholar
  31. 31.
    Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33(6 Suppl):S446–51 discussion S452–453.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2019

Authors and Affiliations

  1. 1.Community Health DepartmentChristian Medical CollegeVelloreIndia

Personalised recommendations